Treace Medical Concepts Inc
Suletud
3.49 -4.9
Ülevaade
Aktsiahinna muutus
24h
Min
3.49
Max
3.73
Sissetulek | -8.6M -18M |
|---|---|
Müük | -15M 47M |
Aktsiakasum | -0.12 |
Kasumimarginaal | -38.055 |
Töötajad | 450 |
EBITDA | -11M -16M |
Soovitused | Osta |
|---|---|
12 kuu keskmine prognoos | +21.95% upside |
Järgmine tulemuste avaldamine | 6. aug 2026 |
|---|
Turukapital | 124M 243M |
|---|---|
Eelmine avamishind | 8.39 |
Eelmine sulgemishind | 3.49 |
Treace Medical Concepts Inc Graafik
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
Seotud uudised
Võrdlus sarnastega
Hinnamuutus
Treace Medical Concepts Inc Prognoos
Hinnasiht
By TipRanks
21.95% tõus
12 kuu keskmine prognoos
Keskmine 4.5 USD 21.95%
Kõrge 7 USD
Madal 2 USD
Põhineb 2 Wall Streeti analüütiku instrumendi Treace Medical Concepts Inc 12 kuu hinnasihil - viimase 3 kuu andmed.
Finantsandmed
Müügi- ja halduskulud
Tegevuskulud
Maksueelne kasum
Müük
Müügikulu
Brutokasum müügist
Intressikulud võla pealt
EBITDA
Ärikasum
$
Ettevõttest Treace Medical Concepts Inc
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
